Autifony Therapeutics initiates QuicK+fire, a pilot study of AUT00063 in adult cochlear implant user

Discussion in 'Research News' started by beeeep, Jul 10, 2016.

    1. beeeep

      beeeep Member

      Location:
      Germany
      Tinnitus Since:
      ~2000, but real bad since 06/2015
      Cause of Tinnitus:
      Unknown
      Seems like they're trying to find other uses for the drug. Reading this it seems like the CLARITY-1 trial is doing better than their QUIT-1 trial (of course this is just speculation)...

      Autifony Press release
       
      • Like Like x 1
      • Agree Agree x 1
      beeeep, Jul 10, 2016
      #1

Share This Page

Loading...
Similar Threads - Autifony Therapeutics initiates
  1. Michael Larsen

    Autifony Therapeutics and Boehringer Ingelheim

    Michael Larsen, Dec 27, 2017, in forum: Research News
    Replies:
    5
    Views:
    1,255
    Danny Boy
    Jan 2, 2018
  2. beeeep

    Update from Autifony Therapeutics’ QUIET-1 Tinnitus Clinical Trial

    beeeep, Apr 29, 2016, in forum: Research News
    Replies:
    5
    Views:
    1,613
    Zechariah
    May 16, 2016
  3. attheedgeofscience

    Autifony Therapeutics Phase II Study for AUT00063, for the Treatment of Hearing Loss and Tinnitus

    attheedgeofscience, Sep 19, 2014, in forum: Research News
    Replies:
    3,619
    Views:
    261,129
    Apolonia
    Feb 28, 2018
  4. Hudson

    Autifony Therapeutics Phase I Study for AUT00063, for the Treatment of Hearing Loss and Tinnitus

    Hudson, May 25, 2013, in forum: Research News
    Replies:
    846
    Views:
    81,829
    Tinnitus Talk
    Oct 18, 2014
  5. earsnothappy

    Autifony's CLARITY-1 (Age-Related Hearing Loss) Phase II Study for AUT00063

    earsnothappy, Oct 15, 2015, in forum: Research News
    Replies:
    23
    Views:
    3,550
    DebInAustralia
    Oct 23, 2016
If you have ringing ears then you've come to the right place. We are a friendly tinnitus support board, dedicated to helping you discuss and understand what tinnitus treatments may work for you.